Dr. Kim on Optimizing Individualized Treatment in Cancer Care

Video

Michelle Miran Kim, MD, discusses optimizing individualized treatment in cancer care.

Michelle Miran Kim, MD, associate professor, Radiation Oncology, director, Medical Student Education, co-chair, Cancer Center Neuro-Oncology Clinical Research Team, Michigan Medicine, the University of Michigan, discusses optimizing individualized treatment in cancer care.

The unprecedented rate of drug development has made it a crucial time to be involved in oncology, Kim says. Developing and executing rational clinical trials will remain important to best optimize the combination of newer therapies with existing treatments, such as radiation therapy, Kim explains.

Due to the abundance of new data and agents, a detailed multidisciplinary discourse is required to optimize care for individual patients, Kim concludes.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,